YB-01(Yuanben (Zhuhai Hengqin) Biotech)

N/A

Report date: 2025/12/23 11:11:39

Base Information

Drug NameYB-01(Yuanben (Zhuhai Hengqin) Biotech)
Drug Alias NameYB-01YB01
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMucin-1 modulators
TargetsMucin-1
Therapy Area/IndicationsSolid tumoursArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesYuanben (Zhuhai Hengqin) Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesYuanben (Zhuhai Hengqin) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A